Literature DB >> 6810986

Immunodiagnosis and sero-epidemiology of malaria.

A Voller, C C Draper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6810986     DOI: 10.1093/oxfordjournals.bmb.a071755

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


× No keyword cloud information.
  6 in total

1.  Specificity of routine parasite serological tests in autoimmune disorders, neoplastic disease, EBV-induced mononucleosis, and HIV infection.

Authors:  W Kern; C Kirsten; P Förster; H J Diesfeld; E Vanek
Journal:  Klin Wochenschr       Date:  1987-10-01

2.  Obscure splenomegaly in the tropics that is not the tropical splenomegaly syndrome.

Authors:  K M DeCock; S B Lucas; P H Rees; A N Hodgen; R A Jupp; B Slavin
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-05

3.  Malaria diagnosis: identification of an anti-40-kDa polypeptide antibody response associated with active or recent infection and study of the IgG/IgM ratio of antibodies to blood-stage Plasmodium falciparum antigens.

Authors:  H C Balthazar-Guedes; M F Ferreira-Da-Cruz; S Montenegro-James; C T Daniel-Ribeiro
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

4.  Inter-observer agreement according to malaria parasite density.

Authors:  Mounkaila Abdou Billo; Mahamadou Diakité; Amagana Dolo; Mouctar Diallo; Belco Poudiougou; Sory Ibrahima Diawara; Eric S Johnson; Janet C Rice; Donald J Krogstad; Ogobara K Doumbo
Journal:  Malar J       Date:  2013-09-22       Impact factor: 2.979

5.  Estimating malaria transmission intensity from Plasmodium falciparum serological data using antibody density models.

Authors:  Emilie Pothin; Neil M Ferguson; Chris J Drakeley; Azra C Ghani
Journal:  Malar J       Date:  2016-02-09       Impact factor: 2.979

Review 6.  Surveillance in easy to access population subgroups as a tool for evaluating malaria control progress: A systematic review.

Authors:  Sanie S S Sesay; Emanuele Giorgi; Peter J Diggle; David Schellenberg; David G Lalloo; Dianne J Terlouw
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.